nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—Paget's disease of bone—osteoporosis	0.132	1	CtDrD
Risedronate—FDPS—osteoporosis	0.114	1	CbGaD
Risedronate—Diphosphonates—Ibandronate—osteoporosis	0.0747	0.305	CiPCiCtD
Risedronate—Diphosphonates—Alendronate—osteoporosis	0.0566	0.231	CiPCiCtD
Risedronate—Diphosphonates—Pamidronate—osteoporosis	0.0566	0.231	CiPCiCtD
Risedronate—Diphosphonates—Etidronic acid—osteoporosis	0.0566	0.231	CiPCiCtD
Risedronate—FDPS—Ibandronate—osteoporosis	0.0548	0.396	CbGbCtD
Risedronate—Ibandronate—osteoporosis	0.0542	0.268	CrCtD
Risedronate—FDPS—Pamidronate—osteoporosis	0.0415	0.3	CbGbCtD
Risedronate—Zoledronate—osteoporosis	0.0382	0.189	CrCtD
Risedronate—Etidronic acid—osteoporosis	0.0382	0.189	CrCtD
Risedronate—Pamidronate—osteoporosis	0.0359	0.177	CrCtD
Risedronate—Alendronate—osteoporosis	0.0359	0.177	CrCtD
Risedronate—FDPS—Alendronate—osteoporosis	0.0218	0.158	CbGbCtD
Risedronate—FDPS—Zoledronate—osteoporosis	0.0203	0.146	CbGbCtD
Risedronate—Histamine Phosphate—Pamidronate—osteoporosis	0.00906	0.068	CrCrCtD
Risedronate—Histamine Phosphate—Alendronate—osteoporosis	0.00906	0.068	CrCrCtD
Risedronate—Zoledronate—Ibandronate—osteoporosis	0.00786	0.059	CrCrCtD
Risedronate—Etidronic acid—Ibandronate—osteoporosis	0.00786	0.059	CrCrCtD
Risedronate—Pamidronate—Ibandronate—osteoporosis	0.00694	0.0521	CrCrCtD
Risedronate—Alendronate—Ibandronate—osteoporosis	0.00694	0.0521	CrCrCtD
Risedronate—Ibandronate—Etidronic acid—osteoporosis	0.0064	0.0481	CrCrCtD
Risedronate—Ibandronate—Zoledronate—osteoporosis	0.0064	0.0481	CrCrCtD
Risedronate—Ibandronate—Alendronate—osteoporosis	0.00602	0.0452	CrCrCtD
Risedronate—Ibandronate—Pamidronate—osteoporosis	0.00602	0.0452	CrCrCtD
Risedronate—Zoledronate—Etidronic acid—osteoporosis	0.00553	0.0415	CrCrCtD
Risedronate—Etidronic acid—Zoledronate—osteoporosis	0.00553	0.0415	CrCrCtD
Risedronate—Zoledronate—Alendronate—osteoporosis	0.0052	0.0391	CrCrCtD
Risedronate—Zoledronate—Pamidronate—osteoporosis	0.0052	0.0391	CrCrCtD
Risedronate—Etidronic acid—Alendronate—osteoporosis	0.0052	0.0391	CrCrCtD
Risedronate—Etidronic acid—Pamidronate—osteoporosis	0.0052	0.0391	CrCrCtD
Risedronate—Alendronate—Zoledronate—osteoporosis	0.00489	0.0367	CrCrCtD
Risedronate—Alendronate—Etidronic acid—osteoporosis	0.00489	0.0367	CrCrCtD
Risedronate—Pamidronate—Zoledronate—osteoporosis	0.00489	0.0367	CrCrCtD
Risedronate—Pamidronate—Etidronic acid—osteoporosis	0.00489	0.0367	CrCrCtD
Risedronate—Alendronate—Pamidronate—osteoporosis	0.0046	0.0345	CrCrCtD
Risedronate—Pamidronate—Alendronate—osteoporosis	0.0046	0.0345	CrCrCtD
Risedronate—FDPS—jaw skeleton—osteoporosis	0.00244	0.433	CbGeAlD
Risedronate—FDPS—periosteum—osteoporosis	0.00184	0.327	CbGeAlD
Risedronate—PTGS2—periosteum—osteoporosis	0.000705	0.125	CbGeAlD
Risedronate—Ibandronate—FDPS—osteoporosis	0.000369	0.343	CrCbGaD
Risedronate—Pamidronate—FDPS—osteoporosis	0.000323	0.3	CrCbGaD
Risedronate—FDPS—uterus—osteoporosis	0.000252	0.0447	CbGeAlD
Risedronate—FDPS—bone marrow—osteoporosis	0.000214	0.038	CbGeAlD
Risedronate—Alendronate—FDPS—osteoporosis	0.00017	0.158	CrCbGaD
Risedronate—Zoledronate—FDPS—osteoporosis	0.000168	0.156	CrCbGaD
Risedronate—PTGS2—uterus—osteoporosis	9.65e-05	0.0171	CbGeAlD
Risedronate—PTGS2—bone marrow—osteoporosis	8.19e-05	0.0145	CbGeAlD
Risedronate—Zoledronate—CA2—osteoporosis	4.63e-05	0.043	CrCbGaD
Risedronate—Abdominal pain—Estropipate—osteoporosis	1.41e-05	0.000484	CcSEcCtD
Risedronate—Skin disorder—Ethinyl Estradiol—osteoporosis	1.41e-05	0.000482	CcSEcCtD
Risedronate—Hepatobiliary disease—Estradiol—osteoporosis	1.4e-05	0.00048	CcSEcCtD
Risedronate—Gastrointestinal pain—Ibandronate—osteoporosis	1.4e-05	0.00048	CcSEcCtD
Risedronate—Arthralgia—Pamidronate—osteoporosis	1.4e-05	0.00048	CcSEcCtD
Risedronate—Myalgia—Pamidronate—osteoporosis	1.4e-05	0.00048	CcSEcCtD
Risedronate—Back pain—Conjugated Estrogens—osteoporosis	1.4e-05	0.000479	CcSEcCtD
Risedronate—Urticaria—Alendronate—osteoporosis	1.4e-05	0.000479	CcSEcCtD
Risedronate—Anxiety—Pamidronate—osteoporosis	1.4e-05	0.000478	CcSEcCtD
Risedronate—Abdominal pain—Alendronate—osteoporosis	1.39e-05	0.000477	CcSEcCtD
Risedronate—Body temperature increased—Alendronate—osteoporosis	1.39e-05	0.000477	CcSEcCtD
Risedronate—Muscle spasms—Conjugated Estrogens—osteoporosis	1.39e-05	0.000476	CcSEcCtD
Risedronate—Sinusitis—Estradiol—osteoporosis	1.39e-05	0.000476	CcSEcCtD
Risedronate—Anaemia—Zoledronate—osteoporosis	1.39e-05	0.000476	CcSEcCtD
Risedronate—Angioedema—Zoledronate—osteoporosis	1.37e-05	0.00047	CcSEcCtD
Risedronate—Gastrointestinal pain—Calcitriol—osteoporosis	1.37e-05	0.00047	CcSEcCtD
Risedronate—Abdominal pain—Raloxifene—osteoporosis	1.37e-05	0.000469	CcSEcCtD
Risedronate—Body temperature increased—Raloxifene—osteoporosis	1.37e-05	0.000469	CcSEcCtD
Risedronate—Urticaria—Ibandronate—osteoporosis	1.36e-05	0.000466	CcSEcCtD
Risedronate—Body temperature increased—Ibandronate—osteoporosis	1.35e-05	0.000464	CcSEcCtD
Risedronate—Abdominal pain—Ibandronate—osteoporosis	1.35e-05	0.000464	CcSEcCtD
Risedronate—Vertigo—Zoledronate—osteoporosis	1.35e-05	0.000462	CcSEcCtD
Risedronate—Syncope—Zoledronate—osteoporosis	1.35e-05	0.000462	CcSEcCtD
Risedronate—Haemoglobin—Estradiol—osteoporosis	1.34e-05	0.000458	CcSEcCtD
Risedronate—Infection—Pamidronate—osteoporosis	1.33e-05	0.000457	CcSEcCtD
Risedronate—Rhinitis—Estradiol—osteoporosis	1.33e-05	0.000457	CcSEcCtD
Risedronate—Urticaria—Calcitriol—osteoporosis	1.33e-05	0.000456	CcSEcCtD
Risedronate—Haemorrhage—Estradiol—osteoporosis	1.33e-05	0.000456	CcSEcCtD
Risedronate—Abdominal pain—Calcitriol—osteoporosis	1.33e-05	0.000454	CcSEcCtD
Risedronate—Body temperature increased—Calcitriol—osteoporosis	1.33e-05	0.000454	CcSEcCtD
Risedronate—Angioedema—Conjugated Estrogens—osteoporosis	1.32e-05	0.000453	CcSEcCtD
Risedronate—Shock—Pamidronate—osteoporosis	1.32e-05	0.000452	CcSEcCtD
Risedronate—Loss of consciousness—Zoledronate—osteoporosis	1.32e-05	0.000452	CcSEcCtD
Risedronate—Pharyngitis—Estradiol—osteoporosis	1.32e-05	0.000452	CcSEcCtD
Risedronate—Hypersensitivity—Estropipate—osteoporosis	1.32e-05	0.000451	CcSEcCtD
Risedronate—Nervous system disorder—Pamidronate—osteoporosis	1.32e-05	0.000451	CcSEcCtD
Risedronate—Urinary tract disorder—Estradiol—osteoporosis	1.31e-05	0.00045	CcSEcCtD
Risedronate—Vomiting—Etidronic acid—osteoporosis	1.31e-05	0.00045	CcSEcCtD
Risedronate—Cough—Zoledronate—osteoporosis	1.31e-05	0.000449	CcSEcCtD
Risedronate—Oedema peripheral—Estradiol—osteoporosis	1.31e-05	0.000449	CcSEcCtD
Risedronate—Connective tissue disorder—Estradiol—osteoporosis	1.31e-05	0.000448	CcSEcCtD
Risedronate—Urethral disorder—Estradiol—osteoporosis	1.3e-05	0.000447	CcSEcCtD
Risedronate—Rash—Etidronic acid—osteoporosis	1.3e-05	0.000446	CcSEcCtD
Risedronate—Dermatitis—Etidronic acid—osteoporosis	1.3e-05	0.000446	CcSEcCtD
Risedronate—Vertigo—Conjugated Estrogens—osteoporosis	1.3e-05	0.000445	CcSEcCtD
Risedronate—Syncope—Conjugated Estrogens—osteoporosis	1.3e-05	0.000444	CcSEcCtD
Risedronate—Hypertension—Zoledronate—osteoporosis	1.3e-05	0.000444	CcSEcCtD
Risedronate—Hypersensitivity—Alendronate—osteoporosis	1.3e-05	0.000444	CcSEcCtD
Risedronate—Headache—Etidronic acid—osteoporosis	1.29e-05	0.000443	CcSEcCtD
Risedronate—Asthenia—Estropipate—osteoporosis	1.28e-05	0.000439	CcSEcCtD
Risedronate—Myalgia—Zoledronate—osteoporosis	1.28e-05	0.000438	CcSEcCtD
Risedronate—Chest pain—Zoledronate—osteoporosis	1.28e-05	0.000438	CcSEcCtD
Risedronate—Arthralgia—Zoledronate—osteoporosis	1.28e-05	0.000438	CcSEcCtD
Risedronate—Anxiety—Zoledronate—osteoporosis	1.27e-05	0.000437	CcSEcCtD
Risedronate—Loss of consciousness—Conjugated Estrogens—osteoporosis	1.27e-05	0.000436	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	1.27e-05	0.000435	CcSEcCtD
Risedronate—Pruritus—Estropipate—osteoporosis	1.26e-05	0.000433	CcSEcCtD
Risedronate—Asthenia—Alendronate—osteoporosis	1.26e-05	0.000433	CcSEcCtD
Risedronate—Hypersensitivity—Ibandronate—osteoporosis	1.26e-05	0.000432	CcSEcCtD
Risedronate—Cough—Conjugated Estrogens—osteoporosis	1.26e-05	0.000432	CcSEcCtD
Risedronate—Dry mouth—Zoledronate—osteoporosis	1.25e-05	0.000429	CcSEcCtD
Risedronate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	1.25e-05	0.000428	CcSEcCtD
Risedronate—Fatigue—Ethinyl Estradiol—osteoporosis	1.25e-05	0.000428	CcSEcCtD
Risedronate—Pruritus—Alendronate—osteoporosis	1.24e-05	0.000427	CcSEcCtD
Risedronate—Eye disorder—Estradiol—osteoporosis	1.24e-05	0.000426	CcSEcCtD
Risedronate—Tinnitus—Estradiol—osteoporosis	1.24e-05	0.000425	CcSEcCtD
Risedronate—Constipation—Ethinyl Estradiol—osteoporosis	1.24e-05	0.000424	CcSEcCtD
Risedronate—Hypersensitivity—Calcitriol—osteoporosis	1.24e-05	0.000423	CcSEcCtD
Risedronate—Cardiac disorder—Estradiol—osteoporosis	1.23e-05	0.000423	CcSEcCtD
Risedronate—Arthralgia—Conjugated Estrogens—osteoporosis	1.23e-05	0.000422	CcSEcCtD
Risedronate—Myalgia—Conjugated Estrogens—osteoporosis	1.23e-05	0.000422	CcSEcCtD
Risedronate—Chest pain—Conjugated Estrogens—osteoporosis	1.23e-05	0.000422	CcSEcCtD
Risedronate—Asthenia—Ibandronate—osteoporosis	1.23e-05	0.000421	CcSEcCtD
Risedronate—Anxiety—Conjugated Estrogens—osteoporosis	1.23e-05	0.00042	CcSEcCtD
Risedronate—Nausea—Etidronic acid—osteoporosis	1.23e-05	0.00042	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	1.22e-05	0.000419	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Pamidronate—osteoporosis	1.22e-05	0.000419	CcSEcCtD
Risedronate—Diarrhoea—Estropipate—osteoporosis	1.22e-05	0.000419	CcSEcCtD
Risedronate—Infection—Zoledronate—osteoporosis	1.22e-05	0.000417	CcSEcCtD
Risedronate—Insomnia—Pamidronate—osteoporosis	1.21e-05	0.000416	CcSEcCtD
Risedronate—Pruritus—Ibandronate—osteoporosis	1.21e-05	0.000415	CcSEcCtD
Risedronate—Angiopathy—Estradiol—osteoporosis	1.21e-05	0.000413	CcSEcCtD
Risedronate—Shock—Zoledronate—osteoporosis	1.21e-05	0.000413	CcSEcCtD
Risedronate—Paraesthesia—Pamidronate—osteoporosis	1.2e-05	0.000413	CcSEcCtD
Risedronate—Diarrhoea—Alendronate—osteoporosis	1.2e-05	0.000412	CcSEcCtD
Risedronate—Asthenia—Calcitriol—osteoporosis	1.2e-05	0.000412	CcSEcCtD
Risedronate—Nervous system disorder—Zoledronate—osteoporosis	1.2e-05	0.000412	CcSEcCtD
Risedronate—Immune system disorder—Estradiol—osteoporosis	1.2e-05	0.000412	CcSEcCtD
Risedronate—Mediastinal disorder—Estradiol—osteoporosis	1.2e-05	0.000411	CcSEcCtD
Risedronate—Dyspnoea—Pamidronate—osteoporosis	1.2e-05	0.00041	CcSEcCtD
Risedronate—Skin disorder—Zoledronate—osteoporosis	1.19e-05	0.000408	CcSEcCtD
Risedronate—Pruritus—Calcitriol—osteoporosis	1.19e-05	0.000407	CcSEcCtD
Risedronate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	1.18e-05	0.000406	CcSEcCtD
Risedronate—Diarrhoea—Raloxifene—osteoporosis	1.18e-05	0.000406	CcSEcCtD
Risedronate—Dyspepsia—Pamidronate—osteoporosis	1.18e-05	0.000405	CcSEcCtD
Risedronate—Dizziness—Estropipate—osteoporosis	1.18e-05	0.000405	CcSEcCtD
Risedronate—Infection—Conjugated Estrogens—osteoporosis	1.17e-05	0.000402	CcSEcCtD
Risedronate—Diarrhoea—Ibandronate—osteoporosis	1.17e-05	0.000402	CcSEcCtD
Risedronate—Mental disorder—Estradiol—osteoporosis	1.16e-05	0.000399	CcSEcCtD
Risedronate—Dizziness—Alendronate—osteoporosis	1.16e-05	0.000399	CcSEcCtD
Risedronate—Shock—Conjugated Estrogens—osteoporosis	1.16e-05	0.000398	CcSEcCtD
Risedronate—Gastrointestinal disorder—Pamidronate—osteoporosis	1.16e-05	0.000397	CcSEcCtD
Risedronate—Nervous system disorder—Conjugated Estrogens—osteoporosis	1.16e-05	0.000397	CcSEcCtD
Risedronate—Malnutrition—Estradiol—osteoporosis	1.16e-05	0.000397	CcSEcCtD
Risedronate—Fatigue—Pamidronate—osteoporosis	1.16e-05	0.000396	CcSEcCtD
Risedronate—Urticaria—Ethinyl Estradiol—osteoporosis	1.15e-05	0.000394	CcSEcCtD
Risedronate—Constipation—Pamidronate—osteoporosis	1.15e-05	0.000393	CcSEcCtD
Risedronate—Pain—Pamidronate—osteoporosis	1.15e-05	0.000393	CcSEcCtD
Risedronate—Diarrhoea—Calcitriol—osteoporosis	1.15e-05	0.000393	CcSEcCtD
Risedronate—Skin disorder—Conjugated Estrogens—osteoporosis	1.15e-05	0.000393	CcSEcCtD
Risedronate—Body temperature increased—Ethinyl Estradiol—osteoporosis	1.14e-05	0.000392	CcSEcCtD
Risedronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	1.14e-05	0.000392	CcSEcCtD
Risedronate—Dizziness—Raloxifene—osteoporosis	1.14e-05	0.000392	CcSEcCtD
Risedronate—Flatulence—Estradiol—osteoporosis	1.14e-05	0.000391	CcSEcCtD
Risedronate—Vomiting—Estropipate—osteoporosis	1.14e-05	0.000389	CcSEcCtD
Risedronate—Dizziness—Ibandronate—osteoporosis	1.13e-05	0.000388	CcSEcCtD
Risedronate—Rash—Estropipate—osteoporosis	1.13e-05	0.000386	CcSEcCtD
Risedronate—Dermatitis—Estropipate—osteoporosis	1.13e-05	0.000386	CcSEcCtD
Risedronate—Back pain—Estradiol—osteoporosis	1.12e-05	0.000384	CcSEcCtD
Risedronate—Headache—Estropipate—osteoporosis	1.12e-05	0.000383	CcSEcCtD
Risedronate—Vomiting—Alendronate—osteoporosis	1.12e-05	0.000383	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Zoledronate—osteoporosis	1.12e-05	0.000383	CcSEcCtD
Risedronate—Muscle spasms—Estradiol—osteoporosis	1.11e-05	0.000381	CcSEcCtD
Risedronate—Rash—Alendronate—osteoporosis	1.11e-05	0.00038	CcSEcCtD
Risedronate—Insomnia—Zoledronate—osteoporosis	1.11e-05	0.00038	CcSEcCtD
Risedronate—Dermatitis—Alendronate—osteoporosis	1.11e-05	0.00038	CcSEcCtD
Risedronate—Headache—Alendronate—osteoporosis	1.1e-05	0.000378	CcSEcCtD
Risedronate—Paraesthesia—Zoledronate—osteoporosis	1.1e-05	0.000377	CcSEcCtD
Risedronate—Vomiting—Raloxifene—osteoporosis	1.1e-05	0.000377	CcSEcCtD
Risedronate—Gastrointestinal pain—Pamidronate—osteoporosis	1.1e-05	0.000376	CcSEcCtD
Risedronate—Dyspnoea—Zoledronate—osteoporosis	1.09e-05	0.000374	CcSEcCtD
Risedronate—Rash—Raloxifene—osteoporosis	1.09e-05	0.000374	CcSEcCtD
Risedronate—Dermatitis—Raloxifene—osteoporosis	1.09e-05	0.000373	CcSEcCtD
Risedronate—Vomiting—Ibandronate—osteoporosis	1.09e-05	0.000373	CcSEcCtD
Risedronate—Headache—Raloxifene—osteoporosis	1.08e-05	0.000371	CcSEcCtD
Risedronate—Rash—Ibandronate—osteoporosis	1.08e-05	0.00037	CcSEcCtD
Risedronate—Dermatitis—Ibandronate—osteoporosis	1.08e-05	0.00037	CcSEcCtD
Risedronate—Dyspepsia—Zoledronate—osteoporosis	1.08e-05	0.00037	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.08e-05	0.000368	CcSEcCtD
Risedronate—Headache—Ibandronate—osteoporosis	1.07e-05	0.000368	CcSEcCtD
Risedronate—Insomnia—Conjugated Estrogens—osteoporosis	1.07e-05	0.000366	CcSEcCtD
Risedronate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.07e-05	0.000366	CcSEcCtD
Risedronate—Vomiting—Calcitriol—osteoporosis	1.07e-05	0.000365	CcSEcCtD
Risedronate—Nausea—Estropipate—osteoporosis	1.06e-05	0.000364	CcSEcCtD
Risedronate—Body temperature increased—Pamidronate—osteoporosis	1.06e-05	0.000364	CcSEcCtD
Risedronate—Abdominal pain—Pamidronate—osteoporosis	1.06e-05	0.000364	CcSEcCtD
Risedronate—Paraesthesia—Conjugated Estrogens—osteoporosis	1.06e-05	0.000363	CcSEcCtD
Risedronate—Gastrointestinal disorder—Zoledronate—osteoporosis	1.06e-05	0.000363	CcSEcCtD
Risedronate—Angioedema—Estradiol—osteoporosis	1.06e-05	0.000362	CcSEcCtD
Risedronate—Rash—Calcitriol—osteoporosis	1.06e-05	0.000362	CcSEcCtD
Risedronate—Fatigue—Zoledronate—osteoporosis	1.06e-05	0.000362	CcSEcCtD
Risedronate—Dermatitis—Calcitriol—osteoporosis	1.06e-05	0.000362	CcSEcCtD
Risedronate—Dyspnoea—Conjugated Estrogens—osteoporosis	1.05e-05	0.000361	CcSEcCtD
Risedronate—Headache—Calcitriol—osteoporosis	1.05e-05	0.00036	CcSEcCtD
Risedronate—Pain—Zoledronate—osteoporosis	1.05e-05	0.000359	CcSEcCtD
Risedronate—Constipation—Zoledronate—osteoporosis	1.05e-05	0.000359	CcSEcCtD
Risedronate—Nausea—Alendronate—osteoporosis	1.05e-05	0.000358	CcSEcCtD
Risedronate—Vertigo—Estradiol—osteoporosis	1.04e-05	0.000356	CcSEcCtD
Risedronate—Dyspepsia—Conjugated Estrogens—osteoporosis	1.04e-05	0.000356	CcSEcCtD
Risedronate—Asthenia—Ethinyl Estradiol—osteoporosis	1.04e-05	0.000356	CcSEcCtD
Risedronate—Syncope—Estradiol—osteoporosis	1.04e-05	0.000356	CcSEcCtD
Risedronate—Nausea—Raloxifene—osteoporosis	1.03e-05	0.000352	CcSEcCtD
Risedronate—Pruritus—Ethinyl Estradiol—osteoporosis	1.02e-05	0.000351	CcSEcCtD
Risedronate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	1.02e-05	0.000349	CcSEcCtD
Risedronate—Fatigue—Conjugated Estrogens—osteoporosis	1.02e-05	0.000349	CcSEcCtD
Risedronate—Nausea—Ibandronate—osteoporosis	1.02e-05	0.000349	CcSEcCtD
Risedronate—Loss of consciousness—Estradiol—osteoporosis	1.02e-05	0.000349	CcSEcCtD
Risedronate—Cough—Estradiol—osteoporosis	1.01e-05	0.000346	CcSEcCtD
Risedronate—Pain—Conjugated Estrogens—osteoporosis	1.01e-05	0.000346	CcSEcCtD
Risedronate—Constipation—Conjugated Estrogens—osteoporosis	1.01e-05	0.000346	CcSEcCtD
Risedronate—Gastrointestinal pain—Zoledronate—osteoporosis	1e-05	0.000343	CcSEcCtD
Risedronate—Hypertension—Estradiol—osteoporosis	9.99e-06	0.000342	CcSEcCtD
Risedronate—Nausea—Calcitriol—osteoporosis	9.96e-06	0.000341	CcSEcCtD
Risedronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.91e-06	0.000339	CcSEcCtD
Risedronate—Hypersensitivity—Pamidronate—osteoporosis	9.89e-06	0.000339	CcSEcCtD
Risedronate—Chest pain—Estradiol—osteoporosis	9.85e-06	0.000338	CcSEcCtD
Risedronate—Myalgia—Estradiol—osteoporosis	9.85e-06	0.000338	CcSEcCtD
Risedronate—Arthralgia—Estradiol—osteoporosis	9.85e-06	0.000338	CcSEcCtD
Risedronate—Anxiety—Estradiol—osteoporosis	9.82e-06	0.000336	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.79e-06	0.000335	CcSEcCtD
Risedronate—Urticaria—Zoledronate—osteoporosis	9.74e-06	0.000334	CcSEcCtD
Risedronate—Body temperature increased—Zoledronate—osteoporosis	9.69e-06	0.000332	CcSEcCtD
Risedronate—Abdominal pain—Zoledronate—osteoporosis	9.69e-06	0.000332	CcSEcCtD
Risedronate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.65e-06	0.000331	CcSEcCtD
Risedronate—Dry mouth—Estradiol—osteoporosis	9.64e-06	0.00033	CcSEcCtD
Risedronate—Asthenia—Pamidronate—osteoporosis	9.63e-06	0.00033	CcSEcCtD
Risedronate—Dizziness—Ethinyl Estradiol—osteoporosis	9.57e-06	0.000328	CcSEcCtD
Risedronate—Pruritus—Pamidronate—osteoporosis	9.49e-06	0.000325	CcSEcCtD
Risedronate—Infection—Estradiol—osteoporosis	9.38e-06	0.000322	CcSEcCtD
Risedronate—Urticaria—Conjugated Estrogens—osteoporosis	9.38e-06	0.000321	CcSEcCtD
Risedronate—Body temperature increased—Conjugated Estrogens—osteoporosis	9.33e-06	0.00032	CcSEcCtD
Risedronate—Abdominal pain—Conjugated Estrogens—osteoporosis	9.33e-06	0.00032	CcSEcCtD
Risedronate—Shock—Estradiol—osteoporosis	9.29e-06	0.000318	CcSEcCtD
Risedronate—Nervous system disorder—Estradiol—osteoporosis	9.26e-06	0.000317	CcSEcCtD
Risedronate—Vomiting—Ethinyl Estradiol—osteoporosis	9.21e-06	0.000315	CcSEcCtD
Risedronate—Diarrhoea—Pamidronate—osteoporosis	9.18e-06	0.000315	CcSEcCtD
Risedronate—Skin disorder—Estradiol—osteoporosis	9.18e-06	0.000314	CcSEcCtD
Risedronate—Rash—Ethinyl Estradiol—osteoporosis	9.13e-06	0.000313	CcSEcCtD
Risedronate—Dermatitis—Ethinyl Estradiol—osteoporosis	9.12e-06	0.000313	CcSEcCtD
Risedronate—Headache—Ethinyl Estradiol—osteoporosis	9.07e-06	0.000311	CcSEcCtD
Risedronate—Hypersensitivity—Zoledronate—osteoporosis	9.03e-06	0.000309	CcSEcCtD
Risedronate—Dizziness—Pamidronate—osteoporosis	8.87e-06	0.000304	CcSEcCtD
Risedronate—Asthenia—Zoledronate—osteoporosis	8.79e-06	0.000301	CcSEcCtD
Risedronate—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.7e-06	0.000298	CcSEcCtD
Risedronate—Pruritus—Zoledronate—osteoporosis	8.67e-06	0.000297	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Estradiol—osteoporosis	8.61e-06	0.000295	CcSEcCtD
Risedronate—Nausea—Ethinyl Estradiol—osteoporosis	8.6e-06	0.000295	CcSEcCtD
Risedronate—Insomnia—Estradiol—osteoporosis	8.54e-06	0.000293	CcSEcCtD
Risedronate—Vomiting—Pamidronate—osteoporosis	8.53e-06	0.000292	CcSEcCtD
Risedronate—Paraesthesia—Estradiol—osteoporosis	8.48e-06	0.000291	CcSEcCtD
Risedronate—Asthenia—Conjugated Estrogens—osteoporosis	8.47e-06	0.00029	CcSEcCtD
Risedronate—Rash—Pamidronate—osteoporosis	8.46e-06	0.00029	CcSEcCtD
Risedronate—Dermatitis—Pamidronate—osteoporosis	8.45e-06	0.00029	CcSEcCtD
Risedronate—Dyspnoea—Estradiol—osteoporosis	8.42e-06	0.000289	CcSEcCtD
Risedronate—Headache—Pamidronate—osteoporosis	8.41e-06	0.000288	CcSEcCtD
Risedronate—Diarrhoea—Zoledronate—osteoporosis	8.39e-06	0.000287	CcSEcCtD
Risedronate—Pruritus—Conjugated Estrogens—osteoporosis	8.35e-06	0.000286	CcSEcCtD
Risedronate—Dyspepsia—Estradiol—osteoporosis	8.32e-06	0.000285	CcSEcCtD
Risedronate—Gastrointestinal disorder—Estradiol—osteoporosis	8.16e-06	0.000279	CcSEcCtD
Risedronate—Fatigue—Estradiol—osteoporosis	8.14e-06	0.000279	CcSEcCtD
Risedronate—Dizziness—Zoledronate—osteoporosis	8.11e-06	0.000278	CcSEcCtD
Risedronate—Pain—Estradiol—osteoporosis	8.08e-06	0.000277	CcSEcCtD
Risedronate—Constipation—Estradiol—osteoporosis	8.08e-06	0.000277	CcSEcCtD
Risedronate—Diarrhoea—Conjugated Estrogens—osteoporosis	8.08e-06	0.000277	CcSEcCtD
Risedronate—Nausea—Pamidronate—osteoporosis	7.97e-06	0.000273	CcSEcCtD
Risedronate—Dizziness—Conjugated Estrogens—osteoporosis	7.8e-06	0.000267	CcSEcCtD
Risedronate—Vomiting—Zoledronate—osteoporosis	7.79e-06	0.000267	CcSEcCtD
Risedronate—Rash—Zoledronate—osteoporosis	7.73e-06	0.000265	CcSEcCtD
Risedronate—Gastrointestinal pain—Estradiol—osteoporosis	7.72e-06	0.000265	CcSEcCtD
Risedronate—Dermatitis—Zoledronate—osteoporosis	7.72e-06	0.000265	CcSEcCtD
Risedronate—Headache—Zoledronate—osteoporosis	7.68e-06	0.000263	CcSEcCtD
Risedronate—Vomiting—Conjugated Estrogens—osteoporosis	7.5e-06	0.000257	CcSEcCtD
Risedronate—Urticaria—Estradiol—osteoporosis	7.5e-06	0.000257	CcSEcCtD
Risedronate—Body temperature increased—Estradiol—osteoporosis	7.47e-06	0.000256	CcSEcCtD
Risedronate—Abdominal pain—Estradiol—osteoporosis	7.47e-06	0.000256	CcSEcCtD
Risedronate—Rash—Conjugated Estrogens—osteoporosis	7.44e-06	0.000255	CcSEcCtD
Risedronate—Dermatitis—Conjugated Estrogens—osteoporosis	7.43e-06	0.000255	CcSEcCtD
Risedronate—Headache—Conjugated Estrogens—osteoporosis	7.39e-06	0.000253	CcSEcCtD
Risedronate—Nausea—Zoledronate—osteoporosis	7.28e-06	0.000249	CcSEcCtD
Risedronate—Nausea—Conjugated Estrogens—osteoporosis	7.01e-06	0.00024	CcSEcCtD
Risedronate—Hypersensitivity—Estradiol—osteoporosis	6.96e-06	0.000238	CcSEcCtD
Risedronate—Asthenia—Estradiol—osteoporosis	6.78e-06	0.000232	CcSEcCtD
Risedronate—Pruritus—Estradiol—osteoporosis	6.68e-06	0.000229	CcSEcCtD
Risedronate—Diarrhoea—Estradiol—osteoporosis	6.46e-06	0.000221	CcSEcCtD
Risedronate—Dizziness—Estradiol—osteoporosis	6.25e-06	0.000214	CcSEcCtD
Risedronate—Vomiting—Estradiol—osteoporosis	6.01e-06	0.000206	CcSEcCtD
Risedronate—Rash—Estradiol—osteoporosis	5.96e-06	0.000204	CcSEcCtD
Risedronate—Dermatitis—Estradiol—osteoporosis	5.95e-06	0.000204	CcSEcCtD
Risedronate—Headache—Estradiol—osteoporosis	5.92e-06	0.000203	CcSEcCtD
Risedronate—Nausea—Estradiol—osteoporosis	5.61e-06	0.000192	CcSEcCtD
